Literature DB >> 8821073

Treatment strategies in Parkinson's disease after a quarter century experiences with L-DOPA therapy.

P A Fischer1.   

Abstract

Parkinson's disease is treated in relation to its symptoms and stage in any individual plan of therapy. L-Dopa treatment is the most effective method of therapy and there is no evidence that would prohibit the early application of L-Dopa. The side-effects and motor complications during long-term L-Dopa treatment have led to give preference to combinations of L-Dopa with other anti-Parkinsonian agents. It is still controversial as to which combination of agents sould be used and whether L-Dopa long-term problems demand the initial introduction of a combination therapy. Another open question is whether neuroprotection is possible in Parkinson's disease with the drugs currently available. In advanced stages of Parkinson's disease treatment of concomitand mental symptoms and multifarious disorders of the autonomic nervous system are becoming of increasing significance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8821073

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  2 in total

1.  L-DOPA modulation of corpus striatal dopamine and dihydroxyphenylacetic acid output from intact and 6-OHDA lesioned rats.

Authors:  K Xu; D E Dluzen
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

2.  Restoring pars intermedia dopamine concentrations and tyrosine hydroxylase expression levels with pergolide: evidence from horses with pituitary pars intermedia dysfunction.

Authors:  Jessica S Fortin; Matthew J Benskey; Keith J Lookingland; Jon S Patterson; Erin B Howey; John L Goudreau; Harold C Schott
Journal:  BMC Vet Res       Date:  2020-09-25       Impact factor: 2.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.